Controlled-release nanoparticulate compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8293277
APP PUB NO 20020012675A1
SERIAL NO

09337675

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are controlled release nanoparticulate formulations comprising a nanoparticulate agent to be administered and a rate-controlling polymer which functions to prolong the release of the agent following administration. The novel compositions release the agent following administration for a time period ranging from about 2 to about 24 hours or longer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALKERMES PHARMA IRELAND LIMITEDCONNAUGHT HOUSE ONE BURLINGTON ROAD DUBLIN 4

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Clancy, Maurice Joseph Anthony Dublin, IE 20 584
Codd, Janet Elizabeth Athlone, IE 14 518
Cumming, Kenneth Iain Essex, GB 17 910
Devane, John G Athlone, IE 27 1757
Hontz, Robert Newton Square, US 8 277
Jain, Rajeev A Framingham, US 24 902
Liversidge, Gary Westchester, US 69 2095
Swanson, Jon North Wales, US 15 491

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation